35 -8 (82) 2025 - Mirzoeva M.R., Nurkhanov F.T. - ASSESSMENT OF LIVER TISSUE CONDITION IN PATIENTS WITH CHRONIC HEPATITIS C: ANALYSIS OF NON-INVASIVE INSTRUMENTAL RESEARCH METHODS

ASSESSMENT OF LIVER TISSUE CONDITION IN PATIENTS WITH CHRONIC HEPATITIS C: ANALYSIS OF NON-INVASIVE INSTRUMENTAL RESEARCH METHODS

Mirzoeva M.R. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Nurkhanov F.T. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Visualization of morphological restructuring of the liver by fibroscanning is a promising method for diagnosing chronic stages of diffuse liver lesions. The aim of the study is to present the results of fibro-steatoscanning in patients with chronic hepatitis C (CHC). Materials and methods. Pilot (short-term) fibro-steatoscanning of the liver was performed in 110 patients. Fibroscan "EchosensVCTEFibroscan 502" (France) was used for visualization. The parameters of liver stiffness (fibrosis) - E (kPa) and steatosis (CAP, dB/m) were studied. Fibroscan "EchosensVCTEFibroscan 502" (France) was used for visualization. The parameters of liver stiffness (fibrosis) - E (kPa) and steatosis (CAP, dB/m) were studied. Probes (XL, M, MyFibroScan application) and various proprietary methods for processing fibroscanning results (P. Nahon et al.; F. Degos et al.; L. Castera et al.; C.S. Pavlov et al.; N. Afdahl et al.) and steatoscanning (M. Sasso et al.; T. Кarlas et al.) were used to process the results. Results. Liver fibrosis and steatosis are characteristic attributes of CHC, reliably established by the method of fibro-, steatoscanning. The methods of processing the results have different diagnostic value, differ in the frequency of diagnosis of fibrosis stages and the degree of steatosis. Conclusion. The introduction of the fibro-steatoscanning method into the programs of clinical examination of the population and patients with CHC will increase the life expectancy of people due to early diagnosis of precirrhotic stages of diffuse liver diseases of any etiology.

Key words: chronic hepatitis C, fibroscan, fibrosis, steatosis, frequency, methods of processing results.

First page

200

Last page

203

For citation:Mirzoeva M.R., Nurkhanov F.T. - ASSESSMENT OF LIVER TISSUE CONDITION IN PATIENTS WITH CHRONIC HEPATITIS C: ANALYSIS OF NON-INVASIVE INSTRUMENTAL RESEARCH METHODS//New Day in Medicine 8(82)2025 200-203 https://newdayworldmedicine.com/en/new_day_medicine/8-82-2025

List of References

1. Borsukov AV, Andreev VG, Gelt TD, Gurbatov SN, Demin IJu, Ivanova EV, Kovalev AV, Kozlova EJu, Mamoshin AV, Morozov MV, Romanov SV, Rudenko OV, Ryhtik PI, Safonov DV, Safonova MA, Timashkov IA; Borsukov AV, ed. Jelastografija sdvigovoj volny: analiz klinicheskih primerov. Smolensk: Smolenskaja gorodskaja tipografija; 2017. 376 p. (Russian).
2. 2017. 376 p. (Russian). Pambrun E, Bouteloup V, de Lédinghen V, Asselineau J, Fraquelli M, Brunetto M, Forns X, Saito H, Nahon P, Pirisi M, Thiébaut R, Perez P. Individual patient data meta analysis of transient elastography diagnostic accuracy in liver fibrosis assessment of chronic hepatitis C patients (TE IPD Study). Journal of Hepatology. 2009;50(Suppl 1):150. https://doi.org/10.1016/S0168-8278(09)60399-8.
3. Borsukov AV, ed. Ultrazvukovaja jelastografija: kak de lat pravilno [Ultrasound elastography: how to do right]. Smolensk: Smolenskaja gorodskaja tipografija; 2018. 120 p. (Russian).
4. Echosens: the liver company [Internet]. Paris (France): Echosens: the liver company. [Table], Quantifying f ibrosis with FibroScan. Available from: fr.zone-secure. net/56337/890880.
5. Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Lédinghen V, Douvin C, Marcellin P, Ganne-Carrié N, Trinchet JC, Beaugrand M. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. Journal of Hepatology. 2008;49(6):1062-1068. doi: 10.1016/j.jhep.2008.08.011.
6. Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, Bedossa P; FIBROSTIC study group. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). Journal of Hepatology. 2010;53(6):1013-1021. jhep.2010.05.035. doi: 10.1016/j.

   file

   download